Signifor Drug Interactions: 87 Major, 123 Moderate
Signifor (Pasireotide) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Signifor. Always confirm against the full prescribing information.
100 interactions
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Pasireotide.
Level 2 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Pasireotide.
Level 1 evidence
Alfuzosin
The metabolism of Alfuzosin can be decreased when combined with Pasireotide.
Level 1 evidence
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Pasireotide.
Level 2 evidence
Alprazolam
The metabolism of Alprazolam can be decreased when combined with Pasireotide.
Level 1 evidence
Anagrelide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Anagrelide.
Level 2 evidence
Aripiprazole
The metabolism of Aripiprazole can be decreased when combined with Pasireotide.
Level 1 evidence
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be decreased when combined with Pasireotide.
Level 1 evidence
Arsenic trioxide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Arsenic trioxide.
Level 2 evidence
Artemether
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Artemether.
Level 2 evidence
Asenapine
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Asenapine.
Level 2 evidence
Atorvastatin
The metabolism of Atorvastatin can be decreased when combined with Pasireotide.
Level 1 evidence
Enter your NPI to unlock 25 major interactions for Signifor
Signifor (Pasireotide) has 452 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Signifor (Pasireotide) has 87 major, 123 moderate, and 242 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Signifor. Always confirm against the full prescribing information.